Long-Term Safety and Effectiveness of Lubiprostone, a Chloride Channel (ClC-2) Activator, in Patients with Chronic Idiopathic Constipation
Open Access
- 19 July 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 56 (9), 2639-2645
- https://doi.org/10.1007/s10620-011-1801-0
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Efficacy and Safety of Lubiprostone in Patients with Chronic ConstipationDigestive Diseases and Sciences, 2009
- Lubiprostone: chronic constipation and irritable bowel syndrome with constipationExpert Opinion on Pharmacotherapy, 2008
- Multicenter, 4-Week, Double-Blind, Randomized, Placebo-Controlled Trial of Lubiprostone, a Locally-Acting Type-2 Chloride Channel Activator, in Patients With Chronic ConstipationThe American Journal of Gastroenterology, 2008
- Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteersAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2006
- Systematic Review on the Management of Chronic Constipation in North AmericaThe American Journal of Gastroenterology, 2005
- PHYSIOLOGICAL FUNCTIONS OF CLC Cl−CHANNELS GLEANED FROM HUMAN GENETIC DISEASE AND MOUSE MODELSAnnual Review of Physiology, 2005
- SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currentsAmerican Journal of Physiology-Cell Physiology, 2004
- Adverse effects of laxativesDiseases of the Colon & Rectum, 2001
- Long term efficacy, safety, and tolerabilitity of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipationGut, 2000
- Epidemiology of colonic symptoms and the irritable bowel syndromeGastroenterology, 1991